Download PDF
Endoscopy 2009; 41(10): 866-871
DOI: 10.1055/s-0029-1215128
DDW highlights

© Georg Thieme Verlag KG Stuttgart · New York

Gastrointestinal bleeding

L.  Cipolletta1 , G.  Rotondano1 , M.  A.  Bianco1
  • 1Division of Gastroenterology, Hospital Maresca, Torre del Greco, Italy
Further Information

Publication History

Publication Date:
01 October 2009 (online)

Also available at
    Permissions and Reprints

Introduction

Gastrointestinal bleeding remains an important clinical challenge. Despite the progress in management of this potentially life-threatening condition, with advances mainly related to effective endoscopic hemostasis and adjuvant pharmacologic treatment, the reported mortality is still around 5 % – 10 % for ulcer bleeding and about 15 % – 20 % for variceal hemorrhage. The continuing large number of abstracts devoted to this subject reflects the persistent interest in this issue. This necessarily subjective selection has included the most noteworthy data, but many abstracts listed only in the second part of the reference list are very interesting.

References

  • 1 Gururatsakul M, Ching K J, Talley N J. et al . Incidence and risk factors of uncomplicated peptic ulcer and bleeding peptic ulcer over a 10-year period.  Gastrointest Endosc. 2009;  69 AB607
    PubMedGoogle Scholar
  • 2 Karsan S S, Kanwal F, Huang E S. et al . Early endoscopy predicts lower mortality in acute gastrointestinal haemorrhage.  Gastroenterology. 2009;  136 (5 Suppl 1) A606
    PubMedGoogle Scholar
  • 3 Marmo R, Rotondano G, Cipolletta L. et al . Artificial neural network vs. Rockall score for prediction of mortality in patients with non variceal upper gastrointestinal bleeding.  Gastrointest Endosc. 2009;  69 AB119
    CrossrefPubMedGoogle Scholar
  • 4 Wyse J M, Barkun A N, Bardou M. et al . Can the presence of endoscopic high-risk stigmata be confidently predicted before gastroscopy?.  Gastrointest Endosc. 2009;  69 AB181
    PubMedGoogle Scholar
  • 5 Cipolletta L, Rotondano G, Bianco M A. et al . Magnification endoscopy can help in improving characterization of visible vessels in peptic ulcer bleeding: a pilot study.  Gastrointest Endosc. 2009;  69 AB119
    CrossrefPubMedGoogle Scholar
  • 6 Pang S H, Tsoi K K, Ching J. et al . Prediction of the need for endoscopic haemostasis in upper gastrointestinal haemorrhage (UGIH): a risk score derivation and validation study.  Gastrointest Endosc. 2009;  69 AB177
    PubMedGoogle Scholar
  • 7 Sung J J, Barkun A N, Kuipers E J. et al . Effect of type of endoscopic haemostasis and adjuvant intravenous esomeprazole on peptic ulcer re-bleeding.  Gastrointest Endosc. 2009;  69 AB617
    PubMedGoogle Scholar
  • 8 Park P O, Rothstein R I, Vassiliou M C. et al . A randomized study comparing haemostasis of laparoscopic clips delivered via flexible endoscopy versus conventional endoscopic clips on porcine mesenteric vessels.  Gastrointest Endosc. 2009;  69 AB163
    PubMedGoogle Scholar
  • 9 Giday S A, Kim Y, Krishnamurty D M. et al . A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.  Gastrointest Endosc. 2009;  69 AB133
    PubMedGoogle Scholar
  • 10 Chiu P W, Joeng H, Choi C. et al . Scheduled 2nd endoscopy or high dose omeprazole infusion in preventing peptic ulcer rebleeding – a prospective randomized trial.  Gastroenterology. 2009;  136 (5, suppl 1) A43
    CrossrefPubMedGoogle Scholar
  • 11 Barkun A N, Sung J J, Kuipers E J. et al . Intravenous esomeprazole for prevention of peptic ulcer re-bleeding in a predominantly caucasian population: results on clinical benefits and hospital resource use.  Gastroenterology. 2009;  136 (5 Suppl 1) A43
    CrossrefPubMedGoogle Scholar
  • 12 Sreedharan A, Martin J, Leontiadis G I. et al . Does proton pump inhibitor (PPI) treatment initiated before endoscopy work in unselected upper gastrointestinal bleeding? A Cochrane systematic review update.  Gastroenterology. 2009;  136 (5 Suppl 1) A44
    CrossrefPubMedGoogle Scholar
  • 13 Barkun A N, Bardou M, Gralnek I M. et al . Impact of elevated INR and of low platelet count on outcomes in acute upper GI bleeding (UGIB).  Gastroenterology. 2009;  136 (5 Suppl 1) A605
    PubMedGoogle Scholar
  • 14 Ortiz V, Ortuno J A, Soler M R. et al . Is really the clinical outcome of non-variceal acute upper gastrointestinal bleeding different in anticoagulated patients.  Gastroenterology. 2009;  136 (5 Suppl 1) A608
    PubMedGoogle Scholar
  • 15 Barkun A N, Bardou M, Gralnek I A. et al . Erythromycin and other prokinetics in acute upper gastrointestinal bleeding? A meta-analysis.  Gastroenterology. 2009;  136 (5 Suppl 1) A636
    PubMedGoogle Scholar
  • 16 Calvet X, Barkun A N, Kuipers E J. et al . Is H. pylori testing clinically useful in the acute setting of upper gastrointestinal bleeding? A systematic review.  Gastroenterology. 2009;  136 (5 Suppl 1) A6
    CrossrefPubMedGoogle Scholar
  • 17 Torres G J, Flores R endon, Leal-Salazar J. et al . The Child–Pugh C score and NSAIDs use as risk factors for five day mortality in cirrhotic patients with non-variceal bleeding.  Gastroenterology. 2009;  136 (5 Suppl 1) A416
    PubMedGoogle Scholar
  • 18 Kantsevoy S V, Dray X, Donatelli G. et al . EUS-guided selective embolization of splenic vein and its branches: A new therapeutic option for variceal bleeding.  Gastrointest Endosc. 2009;  69 AB325
    PubMedGoogle Scholar
  • 19 Chan F KL, Ching J, Au K WL. et al . What is the risk of recurrent lower gastrointestinal bleeding with continued low-dose aspirin therapy? An 8-year prospective cohort study.  Gastroenterology. 2009;  136 (5 Suppl 1) A68
    PubMedGoogle Scholar
  • 20 Jensen D M, Ohning G V, Kovacs T O. et al . Doppler ultrasound probe (DUP) for risk stratification and endoscopic haemostasis of bleeding colonic lesions.  Gastrointest Endosc. 2009;  69 AB289
    PubMedGoogle Scholar
  • 21 Gaddam S, O’Brien J, Trottier S J. Apache II score as a predictor of mortality in ICU in gastrointestinal bleed (GIB) patients.  Gastroenterology. 2009;  136 (5 Suppl 1) A635
    PubMedGoogle Scholar
  • 22 Brullet E, Calvet X, Campo R. et al . Clinical judgement versus risk scores for predicting outcome in patients bleeding from high risk peptic ulcer. Preliminary results of a prospective multicenter study.  Gastroenterology. 2009;  136 (5 Suppl 1) A43-A44
    CrossrefPubMedGoogle Scholar
  • 23 Jensen D M, Stuart R, Ahlbom H. et al . Inter-observer agreement on assessment of photo documentation in bleeding peptic ulcer.  Gastrointest Endosc. 2009;  69 AB186
    PubMedGoogle Scholar
  • 24 Jensen D M, Stuart R, Ahlbom H. et al . Is there a subgroup of patients with Forrest Ib (oozing) peptic ulcer bleeding at increased risk of re-bleeding?.  Gastrointest Endosc. 2009;  69 AB118
    PubMedGoogle Scholar
  • 25 Tellez-Avila F I, Chavez-Tapia N C, López-Arce G. et al . Utility of a new simplified predictive model for predict rebleeding in patients with high-risk stigmata ulcers.  Gastrointest Endosc. 2009;  69 AB185
    PubMedGoogle Scholar
  • 26 Nam J H, Kim J H, Ahn J S. et al . Can we predict the rebleeding within a week after emergent and successful endoscopic haemostasis according to the patterns of non-variceal upper gastrointestinal bleeeding? A multicenter study.  Gastrointest Endosc. 2009;  69 AB176
    PubMedGoogle Scholar
  • 27 Torres J O, Flores R endon, Sandoval M C. et al . Clinical features and risk factors for three-day mortality in elderly patients with non variceal bleeding.  Gastroenterology. 2009;  136 (5 Suppl 1) A607
    CrossrefPubMedGoogle Scholar
  • 28 Lim L G, Lim L L, Teoh P L. et al . Factors associated with mortality in non-variceal and variceal upper gastrointestinal bleed: experience in an Asian tertiary hospital.  Gastroenterology. 2009;  136 (5 Suppl 1) A608
    PubMedGoogle Scholar
  • 29 de Melo S W, Guerriero R, Bhore R. et al . Predicting the cause of upper gastrointestinal haemorrhage: does clinical experience matter?.  Gastroenterology. 2009;  136 (5 Suppl 1) A637
    PubMedGoogle Scholar
  • 30 Suk K T, Kim H S, Kim H J. et al . Risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal haemorrhage.  Gastrointest Endosc. 2009;  69 AB214
    PubMedGoogle Scholar
  • 31 de Melo S W, Guerrero R, Bhore R. et al . Predicting the need for endoscopic therapy in patients with upper gastrointestinal haemorrhage using clinical features.  Gastrointest Endosc. 2009;  69 AB313-AB314
    PubMedGoogle Scholar
  • 32 Saltzman J R, Stenson T H, Thiesen A. et al . Optimizing monopolar coagulation therapy for non-variceal upper gastrointestinal bleeding.  Gastrointest Endosc. 2009;  69 AB118
    PubMedGoogle Scholar
  • 33 Arima S, Ogata S, Tominaga N. et al . Endoscopic haemostasis with high-frequency soft coagulation for bleeding gastric ulcer: comparison with metallic hemoclips in a prospective, randomized study.  Gastrointest Endosc. 2009;  69 AB617
    PubMedGoogle Scholar
  • 34 Andriulli A, Loperfido S, Fornari F. et al . Endoscopic dual versus monotherapy in patients bleeding from high-risk peptic ulcers.  Gastrointest Endosc. 2009;  69 AB205
    PubMedGoogle Scholar
  • 35 Tseng G. Role of endoscopic therapy plus intravenous proton pump inhibitor in uremic patients with high-risk peptic ulcer bleeding – preliminary report of a case-controlled study.  Gastrointest Endosc. 2009;  69 AB179-AB180
    PubMedGoogle Scholar
  • 36 Barkun A N, Wyse J M, Romagnuolo J. et al . Should we be performing routine second-look endoscopy in acute peptic ulcer bleeding in 2009? A meta- analysis.  Gastrointest Endosc. 2009;  69 AB180
    PubMedGoogle Scholar
  • 37 Barkun A N, Teich V, Gralnek I M. et al . The introduction of pre-endoscopy (EGD) high-dose intravenous proton pump inhibition (HDIVPPI) in the management of patients with acute upper gastrointestinal bleeding (UGIB) – a budget impact analysis.  Gastroenterology. 2009;  136 (5 Suppl 1) A63444
    PubMedGoogle Scholar
  • 38 Torres J O, Flores R endon, Sandoval M C. et al . Use of proton pump inhibitors on admission is a protective factor for three day-mortality in non-variceal bleeding (NVB).  Gastroenterology. 2009;  136 (5 Suppl 1) A607
    CrossrefPubMedGoogle Scholar
  • 39 Prakash R, Iduru S V, Shah N R. et al . Pre-endoscopic proton pump inhibitors in non-variceal upper gastrointestinal bleeding; continuous infusion vs. bolus.  Gastroenterology. 2009;  136 (5 Suppl 1) A608
    PubMedGoogle Scholar
  • 40 Leontiadis G I, Martin J, Sharma V K. et al . Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: an updated Cochrane meta-analysis of randomized controlled trials.  Gastroenterology. 2009;  136 (5 Suppl 1) A605
    PubMedGoogle Scholar
  • 41 Cheng H C, Yang H B, Chang W L. et al . Prolonged low-dose omeprazole infusion for 7 days can reduce peptic ulcer re-bleeding for high-risk co-morbid patients.  Gastroenterology. 2009;  136 (5 Suppl 1) A43
    CrossrefPubMedGoogle Scholar
  • 42 Henry M J, Puchakayala B K, Raghavendra M. et al . Retrospective comparison of oral vs. intravenous proton-pump inhibitor therapy in patients with acute peptic ulcer bleeding and high-risk endoscopic stigmata.  Gastroenterology. 2009;  136 (5 Suppl 1) A608
    PubMedGoogle Scholar
  • 43 Yachimski P S, Farrell E, Daniel H unt. et al . Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal bleeding: the impact of standardized guidelines on prescribing practice.  Gastroenterology. 2009;  136 (5 Suppl 1) A636
    PubMedGoogle Scholar
  • 44 Vinogradova Y, Leighton M, Avery A. et al . Increased aspirin use and upper gastrointestinal bleeding rates in socially deprived patients.  Gastroenterology. 2009;  136 (5 Suppl 1) A69
    PubMedGoogle Scholar
  • 45 Leighton M, Vinogradova Y, Shonde A. et al . Diagnostic precision of primary care electronic database for study of gastrointestinal bleeding and its ability to detect the influence of aspirin.  gastroenterology. 2009;  136 (5 Suppl 1) A612
    PubMedGoogle Scholar
  • 46 Cannon M D, Doherty G A, Murray F E. Are undergraduate medical students aware of the risks of upper gastrointestinal haemorrhage associated with commonly prescribed medications?.  Gastroenterology. 2009;  136 (5 Suppl 1) A637
    PubMedGoogle Scholar
  • 47 Doherty G A, Cannon M D, Lynch K M. et al . Risk assessment in the co-prescription of PPIs for gastroprotection: an analysis of what we do and what we think we do.  Gastroenterology. 2009;  136 (5 Suppl 1) A606
    PubMedGoogle Scholar
  • 48 Bretagne J, Nalet B, Lesur G. et al . The prevention of upper gastrointestinal bleeding associated with antiplatelet therapy by proton pump inhibitors (PPI). results of a nested case–control study.  Gastroenterology. 2009;  136 (5 Suppl 1) A634
    PubMedGoogle Scholar
  • 49 Bretagne J, Nalet B, Lesur G. et al . Gastrointestinal bleeding (GIB) and antiplatelet therapy (APT). A French national observational survey including 1010 patients in the hospital setting. Comparison of the results based on the origin of the patients (academic hospital (AH) or community hospital (Ch).  Gastroenterology. 2009;  136 (5 Suppl 1) A635
    PubMedGoogle Scholar
  • 50 John B K, Arramraju S, Shalomov A. et al . The use of antiplatelet agents does not impact the hospital course of patients admitted with GI bleed.  Gastroenterology. 2009;  136 (5 Suppl 1) A634
    PubMedGoogle Scholar
  • 51 Takada J, Araki H, Onogi F. et al . A study on emergency gastro-intestinal endoscopic haemostasis related to anti platelet drugs, anti thrombosis drugs, and non-steroidal anti-inflammatory drugs (NSAIDs).  Gastrointest Endosc. 2009;  69 AB182-AB183
    PubMedGoogle Scholar
  • 52 Ali M A, Chaudhry S, Farooq F T. Acute gastrointestinal bleeding (GIB) in the setting of warfarin use and supratherapeutic INR (ST-INR): frequency of significant endoscopic findings (EF) and independent predictors of GIB.  Gastrointest Endosc. 2009;  69 AB174
    PubMedGoogle Scholar
  • 53 Bretagne J, Nalet B, Lesur G. et al . Characteristics of upper and lower gastrointestinal bleeding associated with antiplatelet therapy (APT). Are there any differences between aspirin and clopidogrel treatment?.  Gastroenterology. 2009;  136 (5 Suppl 1) A634
    PubMedGoogle Scholar
  • 54 Bardou M, Fourrier-Réglat A, Nicholas M. et al . Why do patients at increased risk for gastrointestinal (GI) complication receive ketoprofen despite its poor GI safety profile?: analysis of two databases in Canada and France.  Gastroenterology. 2009;  136 (5 Suppl 1) A635
    PubMedGoogle Scholar
  • 55 Martin J, Connelly S E, Tsui E. et al . Proton pump inhibitors versus H2-receptor antagonists for stress ulcer prophylaxis in mechanically ventilated intensive care patients: a meta-analysis.  Gastroenterology. 2009;  136 (5 Suppl 1) A636
    PubMedGoogle Scholar
  • 56 Calvet X, Barkun A N, Kuipers E J. et al . Is H. pylori testing clinically useful in the acute setting of upper gastrointestinal bleeding? A systematic review.  Gastroenterology. 2009;  136 (5 Suppl 1) A605
    PubMedGoogle Scholar
  • 57 Atreja A, Suchdev K, Vargo J J. Screening for Helicobacter pylori in hospitalized patients with peptic ulcer haemorrhage: are we missing the boat?.  Gastroenterology. 2009;  136 (5 Suppl 1) A606
    PubMedGoogle Scholar
  • 58 Guardiola J, Botargues J M, Berrozpe A. et al . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding. a randomized trial.  Gastrointest Endosc. 2009;  69 AB186
    PubMedGoogle Scholar
  • 59 Karsan S S, Kanwal F, Huang E S. et al . Does the completion of nasogastric lavage (NGL) improve outcomes in GI haemorrhage?.  Gastroenterology. 2009;  136 (5 Suppl 1) A607
    CrossrefPubMedGoogle Scholar
  • 60 Sharma R, Olafsson S, Jackson C S. Clinical presentation and outcomes of Mallory–Weiss syndrome: A VA experience.  Gastroenterology. 2009;  136 (5 Suppl 1) A608
    PubMedGoogle Scholar
  • 61 Manabe N, Hata J, Haruma K. et al . Active gastrointestinal bleeding: detection and localization with contrast-enhanced ultrasonography.  Gastroenterology. 2009;  136 (5 Suppl 1) A44
    CrossrefPubMedGoogle Scholar
  • 62 Park K S, Cho K. Therapeutic efficacy of superselective arterial embolization in patients with gastrointestinal haemorrhage.  Gastroenterology. 2009;  136 (5 Suppl 1) A645
    PubMedGoogle Scholar
  • 63 Flierman A, Kleibeuker J H, Koornstra J J. The incidence of upper gastrointestinal bleeding complications following open heart surgery.  Gastroenterology. 2009;  136 (5 Suppl 1) A606
    PubMedGoogle Scholar
  • 64 Jafri S R, Biswas J, Arora G. et al . Utility and safety of endoscopic procedures in neutropenic patients with gastrointestinal bleeding.  Gastrointest Endosc. 2009;  69 AB313
    PubMedGoogle Scholar
  • 65 Balderas V, Lara L F, Sreenarasimhaiah J. et al . Endoscopy is safe in patients with upper gastrointestinal haemorrhage and low hematocrit.  Gastrointest Endosc. 2009;  69 AB310
    PubMedGoogle Scholar
  • 66 Okanobu H, Tanaka T, Ohya T. A role of colonoscopy in patients with acute lower gastrointestinal bleeding.  Gastrointest Endosc. 2009;  69 AB302
    PubMedGoogle Scholar
  • 67 Bretagne J, Nalet B, Lesur G. et al . Characteristics of upper and lower gastrointestinal bleeding associated with antiplatelet therapy (APT). Are there any differences between aspirin and clopidogrel treatment?.  Gastroenterology. 2009;  136 (5 Suppl 1) A634
    PubMedGoogle Scholar
  • 68 Correa P, Averbach M, Paccos J. et al . Endoscopic management of massive acute lower gastrointestinal bleeding.  Gastrointest Endosc. 2009;  69 AB288
    PubMedGoogle Scholar
  • 69 Correa P, Lobo E J, Averbach M. et al . Efficacy and safety of argon plasma coagulation for the treatment of hemorrhagic radiation proctitis.  Gastrointest Endosc. 2009;  69 AB279-AB230
    PubMedGoogle Scholar
  • 70 Duraiswamy S, Schmulewitz N, Rockey D C. The role of technetium-99 labeled erythrocyte scintigraphy in the evaluation of patients with lower gastrointestinal haemorrhage.  Gastrointest Endosc. 2009;  69 AB284
    PubMedGoogle Scholar
  • 71 Lyles T E, Naik S, Rockey D C. Outcomes in cirrhotics with upper gastrointestinal haemorrhage – importance of the etiology of bleeding.  Gastroenterology. 2009;  136 (5 Suppl 1) A825
    PubMedGoogle Scholar
  • 72 Gana J C, Turner D, Avitzur Y. et al . Prediction of esophageal variceal bleeding in children.  Gastroenterology. 2009;  136 (5 Suppl 1) A825
    PubMedGoogle Scholar
  • 73 Satoskar R S, Mayorga C A, Reddy K G. et al . Adherence to standard of care measures in suspected acute variceal bleeding.  Gastroenterology. 2009;  136 (5 Suppl 1) A825
    PubMedGoogle Scholar
  • 74 Stein L L, Mazhar S M, Gabbert C. et al . Esophageal variceal band ligation (EVL) plus beta-blocker (BB) treatment in the primary prophylaxis of esophageal variceal bleeding.  Gastroenterology. 2009;  136 (5 Suppl 1) A826
    PubMedGoogle Scholar
  • 75 Iwase H, Shimada M, Hirashima N. et al . Long-term endoscopic obliteration with cyanoacrylate glue for isolated gastric variceal bleeding – a 15-year prospective evaluation.  Gastrointest Endosc. 2009;  69 AB119
    CrossrefPubMedGoogle Scholar
  • 76 Lee J W, Kim H, Park J H. et al . Oral ciprofloxacin versus intravenous ceftriaxone in the prophylaxis of infections in patients with decompensated liver cirrhosis and gastrointestinal haemorrhage – preliminary result.  Gastroenterology. 2009;  136 (5 Suppl 1) A824
    CrossrefPubMedGoogle Scholar
  • 77 Cardenas A, Pritchett S, Brown R S. et al . The effects of long term PEG-interferon therapy on the development of esophageal varices and variceal bleeding in patients with hepatitis C and advanced fibrosis: final results from the copilot trial.  Gastroenterology. 2009;  136 (5 Suppl 1) A795
    PubMedGoogle Scholar
  • 78 Somsouk M, Aslam R, Ali M. et al . Esophageal varices on computed tomography predicts variceal haemorrhage.  Gastrointest Endosc. 2009;  69 AB355-AB356
    PubMedGoogle Scholar
  • 79 Moodley J, Lopez R, Carey W D. The impact of practice guideline (PG) compliance on prevention of first esophageal variceal haemorrhage. (EVH) in patients with cirrhosis – a validation study.  Gastroenterology. 2009;  136 (5 Suppl 1) A824
    CrossrefPubMedGoogle Scholar
  • 80 Nguyen K C, Nguyen T H. Efficacy of endoscopic multi-site band ligation in eradicating esophageal varices.  Gastrointest Endosc. 2009;  69 AB222
    PubMedGoogle Scholar
  • 81 Dell’Era A, Iannuzzi F, Fabris F M. et al . Influence of portal vein thrombosis (PVT) on the efficacy of variceal band ligation.  Gastroenterology. 2009;  136 (5 Suppl 1) A825
    PubMedGoogle Scholar
  • 82 Miyata Y, Furuichi Y, Ichimura S. et al . Safe injection method for a cyanoacrylate monomer (CA) in the treatment of gastric fundal variceal rupture.  Gastrointest Endosc. 2009;  69 AB261-AB262
    PubMedGoogle Scholar
  • 83 Safwat W. The use of N-2-butyl cyanoacrylate as a rescue therapy for re-bleeding and uncontrollable bleeding from esophageal varices.  Gastrointest Endosc. 2009;  69 AB118-AB119
    PubMedGoogle Scholar
  • 84 Cheung J, Zeman M, van Zanten S V. et al . A systematic review and meta-analysis of secondary prophylaxis with band ligation, pharmacotherapy or combination therapy after esophageal variceal bleeding.  Gastrointest Endosc. 2009;  69 AB284
    PubMedGoogle Scholar

L. CipollettaMD 

Department of Gastroenterology Hospital Maresca

Via Montedoro
80059 Torre del Greco
Italy

Fax: +39-081.8490109

Email: livio.cipolletta@alice.it

      >